52P The inducible Medigene T-cell receptor (iM-TCR) controls cytotoxicity of tumor-specific TCR-modified T-cells with improved avidity through control of TCR surface expression
Year: 2021
Type: article
Source: Annals of Oncology
Institution: Medigene (Germany)
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4200535319